AstraZeneca on Friday (October 10, 2025) became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration that avoided its threats of steep tariffs.
President Donald Trump made the announcement in the Oval Office with AstraZeneca CEO Pascal Soriot, who said that during tough negotiations to reach a deal, Mr. Trump and his team of officials had “really kept me up at night.”
Under the agreement, AstraZeneca will charge most-favoured-nation
Continue Reading on The Hindu
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.